STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

Estimated average burden
OMB Number:			3235-0287
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZELINGER JOSEF

(Last)

(First)

(Middle)

302, 6 BUTLER STREET

(Street)

CAMBERWELL, VIC

3124

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Propanc Biopharma, Inc. [ PPCB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

**Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned**
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								2,805⁽¹⁾⁽²⁾	D

**Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned**
**(e.g., puts, calls, warrants, options, convertible securities)**
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock Purchase Warrant	$0.01	07/05/2023		A		15,000,000⁽³⁾		07/05/2023	07/05/2026	Common Stock	15,000,000	$0⁽⁴⁾	15,000,000⁽³⁾	I	By Aggro Investments Pty Ltd⁽³⁾

Explanation of Responses:

1. On May 1, 2023, the issuer effected a 1-for-1,000 reverse stock split (the "Reverse Split") of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"). The number of shares of Common Stock reported on this Form 4 has been adjusted to reflect the Reverse Split as it pertained to the number of shares of Common Stock that the reporting person held immediately following the Reverse Split.

2. The reporting person's Form 3 filed on August 20, 2021 inadvertently failed to report an additional 5 shares of Common Stock directly owned in error. Due to the method of rounding fractional shares of Common Stock held by the reporting person after the Reverse Split, the number of shares of Common Stock reported on this Form 4 has also been adjusted to correct the reporting person's total ownership as of August 23, 2023.

3. Due to an administrative error, the reporting person inadvertently failed to report the beneficial ownership of the common stock purchase warrant (the "Warrant") issued to Aggro Investments Pty Ltd ("Aggro Investments") on July 5, 2023. The Warrant is currently exercisable, with shares of Common Stock issuable upon exercise subject to a 4.99% blocker based upon the aggregate number of shares of Common Stock outstanding on the date of such exercise. The reporting person wholly owns and controls Aggro Investments, but disclaims beneficial ownership of the Warrant and shares issuable pursuant to its exercise, except to the extent of the reporting person's pecuniary interest therein.

4. Reflects the receipt of the Warrant for no additional consideration in connection with a loan from Aggro Investments to the issuer on July 5, 2023.

	/s/ Josef Zelinger	08/23/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.